[go: up one dir, main page]

BR9714066A - Processo para a preparação de derivados de tiazol. - Google Patents

Processo para a preparação de derivados de tiazol.

Info

Publication number
BR9714066A
BR9714066A BR9714066-0A BR9714066A BR9714066A BR 9714066 A BR9714066 A BR 9714066A BR 9714066 A BR9714066 A BR 9714066A BR 9714066 A BR9714066 A BR 9714066A
Authority
BR
Brazil
Prior art keywords
compound
formula
preparation
converting
thiazole derivatives
Prior art date
Application number
BR9714066-0A
Other languages
English (en)
Other versions
BR9714066B1 (pt
Inventor
Thomas Pitterna
Henry Szczepanski
Peter Maienfisch
Ottmar Franz Hueterf
Thomas Rapold
Marcel Senn
Thomas Goebel
Anthony Cornelius O'sullivan
Gottfried Seifert
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9714066A publication Critical patent/BR9714066A/pt
Publication of BR9714066B1 publication Critical patent/BR9714066B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Eyeglasses (AREA)

Abstract

Patente de Invenção: <B>"PROCESSO PARA A PREPARAçãO DE DERIVADOS DE TIAZOL"<D>. A invenção refere-se a um processo para a preparação de um composto da fórmula em que Q, Y, Z, R1, R2, R3, R4 e R5 são conforme definido na especificação, o que compreende a) reação de um composto da fórmula com um composto halogenante para formar um composto da fórmula ou b) conversão de um composto de fórmula (II) por meio de um agente halogenante em um composto da fórmula; opcionalmente c) conversão do composto de fórmula (IV) em um composto da fórmula (III); d) conversão de um composto de fórmula (III) por meio de um composto da fórmula (V) em um composto da fórmula ou e) conversão de um composto (IV) por meio de um composto (V) em um composto (VI); e f) conversão de um composto (VI) por meio de um agente de cloração em composto (I); um composto (IV); a um processo para a preparação de um composto (III) e a um processo para a preparação de um composto (IV).
BRPI9714066-0A 1996-12-19 1997-12-17 processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço. BR9714066B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH312496 1996-12-19
PCT/EP1997/007087 WO1998027074A1 (en) 1996-12-19 1997-12-17 Process for the preparation of thiazole derivatives

Publications (2)

Publication Number Publication Date
BR9714066A true BR9714066A (pt) 2000-05-09
BR9714066B1 BR9714066B1 (pt) 2009-01-13

Family

ID=4249128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9714066-0A BR9714066B1 (pt) 1996-12-19 1997-12-17 processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço.

Country Status (24)

Country Link
US (3) US6121455A (pt)
EP (1) EP0946531B1 (pt)
JP (1) JP4275742B2 (pt)
KR (1) KR100525937B1 (pt)
CN (2) CN1086388C (pt)
AR (1) AR008539A1 (pt)
AT (1) ATE308531T1 (pt)
AU (1) AU727669B2 (pt)
BR (1) BR9714066B1 (pt)
CA (1) CA2274177C (pt)
CZ (1) CZ296558B6 (pt)
DE (1) DE69734526T2 (pt)
DK (1) DK0946531T3 (pt)
ES (1) ES2251747T3 (pt)
HU (1) HU225458B1 (pt)
ID (1) ID22398A (pt)
IL (1) IL130298A (pt)
IN (1) IN2012DE00109A (pt)
PL (1) PL196029B1 (pt)
RU (1) RU2191775C2 (pt)
TW (1) TW432056B (pt)
UA (1) UA54473C2 (pt)
WO (1) WO1998027074A1 (pt)
ZA (1) ZA9711358B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100525937B1 (ko) * 1996-12-19 2005-11-08 신젠타 파티서페이션즈 아게 티아졸 유도체의 제조방법
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
TWI359810B (en) 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
CN102177999B (zh) * 2011-04-03 2015-08-26 普洱市思茅区梆尔茶业有限公司 一种保健茶粉及其加工工艺和用途
CN103242258A (zh) * 2013-05-13 2013-08-14 南京工业大学 一种噻虫胺合成工艺
JP6643763B2 (ja) * 2014-02-03 2020-02-12 国立大学法人 東京大学 アゾール誘導体骨格を有するペプチドの製造方法
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
WO2022200364A1 (en) 2021-03-25 2022-09-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
EP4337016A1 (en) 2021-05-14 2024-03-20 Syngenta Crop Protection AG Seed treatment compositions
JP2024516912A (ja) 2021-05-14 2024-04-17 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 昆虫、ダニ目及び線虫有害生物の防除
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105064A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105065A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712307A1 (de) * 1987-04-10 1988-10-20 Bayer Ag 3-substituierte 1-(2-chlor-thiazol-5-yl-methyl)-2- nitroimino-1,3-diazacycloalkane
IE960442L (en) * 1988-12-27 1990-06-27 Takeda Chemical Industries Ltd Guanidine derivatives, their production and insecticides
IL99161A (en) * 1990-08-17 1996-11-14 Takeda Chemical Industries Ltd History of guanidine A process for their preparation and preparations from pesticides that contain them
TW198724B (pt) * 1990-10-24 1993-01-21 Ciba Geigy Ag
ATE236139T1 (de) * 1995-09-11 2003-04-15 Syngenta Participations Ag Verfahren zur herstellung von 2-chlor-5- chlomethyl-thiazol-derivaten
ZA9610046B (en) * 1995-12-01 1997-07-10 Ciba Geigy Process for preparing 2-chlorothiazole compounds
DK0873327T3 (da) * 1995-12-21 2004-11-22 Syngenta Participations Ag Fremgangsmåde til fremstilling af 2-chlor-5-chlormethyl-thiazol
KR100525937B1 (ko) * 1996-12-19 2005-11-08 신젠타 파티서페이션즈 아게 티아졸 유도체의 제조방법

Also Published As

Publication number Publication date
CA2274177C (en) 2007-09-18
HUP0000524A2 (hu) 2000-06-28
EP0946531A1 (en) 1999-10-06
IN2012DE00109A (pt) 2015-05-08
AU727669B2 (en) 2000-12-21
CZ219599A3 (cs) 1999-09-15
BR9714066B1 (pt) 2009-01-13
US6677457B2 (en) 2004-01-13
US6369233B1 (en) 2002-04-09
HU225458B1 (en) 2006-12-28
KR100525937B1 (ko) 2005-11-08
AU5759298A (en) 1998-07-15
TW432056B (en) 2001-05-01
AR008539A1 (es) 2000-01-19
EP0946531B1 (en) 2005-11-02
ES2251747T3 (es) 2006-05-01
US20030065191A1 (en) 2003-04-03
JP2001506254A (ja) 2001-05-15
WO1998027074A1 (en) 1998-06-25
UA54473C2 (uk) 2003-03-17
CN1086388C (zh) 2002-06-19
CN1241182A (zh) 2000-01-12
ZA9711358B (en) 1998-07-08
DE69734526D1 (de) 2005-12-08
JP4275742B2 (ja) 2009-06-10
DE69734526T2 (de) 2006-07-13
HUP0000524A3 (en) 2001-02-28
CZ296558B6 (cs) 2006-04-12
CA2274177A1 (en) 1998-06-25
CN1397552A (zh) 2003-02-19
IL130298A (en) 2004-03-28
CN1196688C (zh) 2005-04-13
PL333925A1 (en) 2000-01-31
RU2191775C2 (ru) 2002-10-27
PL196029B1 (pl) 2007-11-30
IL130298A0 (en) 2000-06-01
ATE308531T1 (de) 2005-11-15
DK0946531T3 (da) 2006-02-13
KR20000069615A (ko) 2000-11-25
US6121455A (en) 2000-09-19
ID22398A (id) 1999-10-07

Similar Documents

Publication Publication Date Title
BR9714066A (pt) Processo para a preparação de derivados de tiazol.
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
FI964520A (fi) Atsabisykloyhdisteet
CO4820391A1 (es) Compuestos hipolipidemicos de benzotiazepina
HU9401415D0 (en) Enzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives, pharmaceutical compositions contaning them, and process for producing them
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
FI955885A0 (fi) Vesipohjaiset organopolysiloksaanipitoiset koostumukset, niiden valmistusmenetelmä ja käyttö
FI955884A (fi) Vesipohjaiset organopolysiloksaanipitoiset koostumukset, niiden valmistusmenetelmä ja käyttö
FR2515179B1 (pt)
ZA948078B (en) Inclusion complex.
SI1077218T1 (sl) Peptido-mimetiäśne spojine, ki vsebujejo sekvenco rgd, uporabne kot inhibitorji integrinov
FI101376B1 (fi) Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
BR9901378A (pt) Processo de purificação de uma solução aquosa em relação a compostos orgânicos..
ATE48835T1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
BRPI0409069A (pt) compostos quìmicos
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9909841A (pt) Derivados de pirazolinona, agente de controle de doença das plantas, compostos de pirazolinona, processo para controlar doenças das plantas, e, uso dos derivados de pirazolinona
BR9808854A (pt) Processo para preparação de um composto, e, composto
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
BR0009453A (pt) Processo para a preparação de um composto
PT1257552E (pt) Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose
ID27440A (id) Proses untuk menyiapkan penengah-penengah
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.
DE69004320D1 (de) Hydroxyphenethylamin-Derivat und dessen Salze, Verfahren zur Herstellung, medizinische Verwendung und Verwendung als spezifisches pharmakologisches Werkzeug.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SYNGENTA PARTICIPATIONS AG (CH)

Free format text: TRANSFERIDO DE: NOVARTIS AG (NOVARTIS SA) (NOVARTIS INC.)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.